ABVX - Episodic Pivot - 2025-08-20
ABVX Trade Summary
Performance metrics and trade details for ABVX breakout.
- Stage
- 2
- Catalyst
- New Product
- Risk
- 3.8%
- Gain %
- 17.0%
- Market Condition
- Bullish
- Market Cap
- $5.19B
- Shares Float
- 68.74M
- Entry
- Breakout
- Stop
- LoD
- Exit
- 10 EMA
- About
The stock surged sharply following the announcement of highly positive Phase 3 trial results for its lead drug candidate, Obefazimod (ABX464).
After the initial spike, it provided an excellent delayed entry opportunity about three weeks later.
After Breakout
Top Similar Stocks for ABVX
| Rank | Ticker | Score |
|---|---|---|
| 1 | SYRE |
42%
|